申请人:Merck Sharp & Dohme Ltd.
公开号:US06355798B1
公开(公告)日:2002-03-12
1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent as the 3-position and an amino moiety at the 6-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
1,2,4-三唑并[4,3-b]吡啶嗪衍生物,具有在3位可选择取代的环烷基、苯基或杂环烷基取代基,以及在6位处的氨基基团,是GABAA受体的选择性配体,特别具有高亲和力与其α2和/或α3亚基,对于焦虑和抽搐的治疗是有用的。